5-Hydroxytryptamine1AReceptor Agonists in Animal Models of Depression and Anxiety
- 1 July 1992
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 71 (1), 24-30
- https://doi.org/10.1111/j.1600-0773.1992.tb00515.x
Abstract
The effects of different doses of buspirone, 3-dipropyl-amino-5-hydrochromar (NDO 008) and 8-hydroxydipropyl-aminotetralin (8-OH-DPAT) (administered intraperitoneally) were studied in tests of anxiolytic and antidepressant action in rats. These tests included the elevated plus maze test, the forced swim test, stress-induced suppression of open-field behavior, and the differential-reinforcement-of-low-rates-of-behaviour-72 sec (DRL 72 s) test. Buspirone (0.125 mg/kg) and NDO 008 (1.0 to 2.0 mg/kg) produced anxiolytic activity in the elevated plus maze, whereas 8-OH-DPAT did not in the doses employed. All three compounds increased activity in the forced swim test, although buspirone did so at a lower dose than NDO 008 and 8-OH-DPAT. In the stress-induced suppression test of open field activity all three compounds induced an antidepressant-like effect at different doses dependent on whether footshock (stressor) was presented 24 hr before or just prior to the open-field test. All three compounds even caused some reduction of activity in the non-shocked rats. 8-OH-DPAT (1.0 mg/kg) produced a significant and reliable increase in the Reinforcement/Response rate quotient in the DRL 72s test. These diverse results may provide an indication of potential clinical efficacy of the 5-HT1A agonists in the treatment of anxiety and depression.Keywords
This publication has 32 references indexed in Scilit:
- 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalisEuropean Journal of Pharmacology, 1988
- Is the forced swimming test a suitable model for revealing antidepressant activity?Psychopharmacology, 1988
- Comparison of Desipramine, Amitriptyline, Zimeldine and Alaproclate in Six Animal Models Used to Investigate Antidepressant DrugsBasic & Clinical Pharmacology & Toxicology, 1988
- Different effects of intracerebral and systemic administration of buspirone in the forced swimming test: Involvement of a metaboliteLife Sciences, 1988
- Effect of a Serotonin and Noradrenaline Uptake Inhibitor in Panic Disorder; a Double-blind Comparative Study with Fluvoxamine and MaprotilineInternational Clinical Psychopharmacology, 1988
- Potential antidepressant properties of 8-hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonistEuropean Journal of Pharmacology, 1987
- Buspirone attenuates learned helplessness behavior in ratsDrug Development Research, 1987
- 1-(2-Pyrimidinyl)-Piperazine as Active Metabolite of Buspirone in Man and RatPharmacology, 1986
- Serotonin receptor changes after chronic antidepressant treatments: Ligand binding, electrophysiological, and behavioral studiesLife Sciences, 1983
- The comparative efficacy of buspirone and diazepam in the treatment of anxietyAmerican Journal of Psychiatry, 1979